lactic acid has been researched along with enoximone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bahawar, H; Dieterich, HA; Mitrovic, V; Neuzner, J; Schlepper, M; Thormann, J; Volz, M | 1 |
| Amin, DK; Hulse, S; Shah, PK; Shellock, FG; Swan, HJ | 1 |
| Adler, G; Beckh, K; Georgieff, M; Schricker, T; Weidenbach, H | 1 |
| Hoeft, A; Kazmaier, S; Sonntag, H; Stephan, H | 1 |
| Branzi, A; Caldarera, I; Galie, N; Grattoni, C; Magnani, B; Magnani, G; Melandri, G; Rapezzi, C | 1 |
| Fiege, M; Gerbershagen, MU; Kolodzie, K; Schulte Am Esch, J; Wappler, F; Weisshorn, R | 1 |
1 trial(s) available for lactic acid and enoximone
| Article | Year |
|---|---|
Effects of enoximone and R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease.
Topics: Adult; Aged; Cardiotonic Agents; Catecholamines; Coronary Circulation; Enoximone; Heart; Hemodynamics; Humans; Imidazoles; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Phosphodiesterase Inhibitors; Quinazolines; Vasodilator Agents; Ventricular Function, Left | 1994 |
6 other study(ies) available for lactic acid and enoximone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease.
Topics: Atrial Natriuretic Factor; Catecholamines; Coronary Circulation; Coronary Disease; Enoximone; Hemodynamics; Humans; Imidazoles; Lactates; Lactic Acid; Middle Aged; Neurotransmitter Agents; Phosphodiesterase Inhibitors; Prostaglandins | 1989 |
Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
Topics: Aged; Blood Flow Velocity; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Lactates; Lactic Acid; Male; Middle Aged; Myocardium; Oxygen Consumption | 1984 |
Enhancement of hepatic glucose release and bile flow by the phosphodiesterase-III-inhibitor enoximone in the perfused rat liver.
Topics: Animals; Bile; Calcium; Carbohydrate Metabolism; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Epinephrine; Glucagon; Glucose; Lactates; Lactic Acid; Liver; Male; Norepinephrine; Perfusion; Phenylephrine; Protein Kinase C; Rats; Rats, Wistar; Second Messenger Systems; Secretory Rate; Stimulation, Chemical | 1995 |
Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Coronary Circulation; Drug Synergism; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption | 1993 |
In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Body Temperature; Carbon Dioxide; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Enoximone; Female; Hydrogen-Ion Concentration; Lactic Acid; Male; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Phosphodiesterase Inhibitors; Swine | 2003 |